Aggressive ablation vs. regular ablation for persistent atrial fibrillation: a multicentre real-world cohort study
Europace · 2025
DOI: 10.1093/europace/euaf045 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Europace, 2025. Verfasst von Kaige Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai Jiao Tong University School of Medicine, Shanghai Chest Hospital, No. 241 West Huaihai Road, Shanghai 200030, Chin…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Pulmonary Veins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Grants from the National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
Current guidelines for the optimal ablation strategy for persistent atrial fibrillation (PerAF) remain unclear. While our previous RCT confirmed the favourable prognosis of aggressive ablation, real-world evidence is still lacking. Methods and results Among 4833 PerAF patients undergoing catheter ablation at 10 centres, two groups were defined: regular ablation (PVI-only or PVI plus anatomical ablation) and aggressive ablation (anatomical plus electrogram-guided ablation), with 1560 patients each after propensity score (PS) matching. The primary endpoint was 12-month AF/atrial tachycardia (AT) recurrence-free survival off anti-arrhythmic drugs after a single procedure. Additional PS matching was performed within the regular group between PVI-only and anatomical ablation (n = 455 each). Furthermore, anatomical ablation from the regular group was independently matched with aggressive ablation (n = 1362 each). At 12 months, the aggressive group showed superior AF/AT-free survival (66.2% vs. 59.3%, P < 0.001; HR 0.745), similar AT recurrence (12.0% vs. 11.3%, P = 0.539), and significantly higher procedural AF termination (67.0% vs. 21.0%, P < 0.001) than regular group. Moreover, patients with AF termination had improved AF/AT-free survival (72.3% vs. 55.2%, P < 0.001). Safety endpoints did not differ significantly between the two groups. Both the ablation outcomes and AF termination rate showed increasing trends with the extent of ablation aggressiveness but declined with extremely aggressive ablation. After additional PS matching, within the regular group, no statistical differences were observed though AF/AT-free survival in the anatomical group was slightly higher than the PVI-only group (60.7% vs. 55.6%, P = 0.122); while aggressive ablation showed improved AF/AT-free survival compared to anatomical ablation alone from regular group (67.5% vs. 59.9%, P < 0.001).
Conclusion
Aggressive ablation achieved more favourable outcomes than regular ablation, and moderately aggressive ablation may be associated with better clinical outcomes. AF termination is a reliable ablation endpoint.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Shanghai Jiao Tong University School of Medicine, Shanghai Chest Hospital, No. 241 West Huaihai Road, Shanghai 200030, China.
- Department of Cardiology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, No. 160 Pujian Road, Shanghai 200127, China.
- Department of Cardiology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, No. 26 Shengli Street, Jiang'an District, Wuhan City, Hubei 430014, China.
- Department of Cardiology, Xuzhou Central Hospital, No. 199 South Jiefang Road, Xuzhou City, Jiangsu 221009, China.
- Department of Cardiology, Yuhuan Second People's Hospital, No. 77 Huanbao Road, Yuhuan City, Zhejiang 317600, China.
- Department of Cardiology, Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, No. 1 Jingba Road, Jinan City, Shandong 25000, China.
ORCID-Profile: Kaige Li, Bing Han, Yanzhe Wang, Shaohui Wu, Mu Qin, Xu Liu
Förderung
- Grants from the National Natural Science Foundation of China
Zitieren
APA
Li, K., Shi, Y., Wang, X., Ye, P., Han, B., Jiang, W., Zhang, Y., Zheng, Q., Ji, A., Zhang, M., Wang, Y., Wu, S., Xu, K., Qin, M., Liu, X., & Hou, X. (2025). Aggressive ablation vs. regular ablation for persistent atrial fibrillation: a multicentre real-world cohort study. Europace. https://doi.org/10.1093/europace/euaf045
Vancouver
Li K, Shi Y, Wang X, Ye P, Han B, Jiang W, et al. Aggressive ablation vs. regular ablation for persistent atrial fibrillation: a multicentre real-world cohort study. Europace. 2025. doi:10.1093/europace/euaf045
BibTeX
@article{Li2025,
author = {Li, Kaige and Shi, Yangbin and Wang, Xinhua and Ye, Ping and Han, Bing and Jiang, Weifeng and Zhang, Yu and Zheng, Qidong and Ji, Anjing and Zhang, Menghe and Wang, Yanzhe and Wu, Shaohui and Xu, Kai and Qin, Mu and Liu, Xu and Hou, Xumin},
title = {Aggressive ablation vs. regular ablation for persistent atrial fibrillation: a multicentre real-world cohort study},
journal = {Europace},
year = {2025},
doi = {10.1093/europace/euaf045}
}
EUVIMED